INSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Front Immunol. 2018 May 17;9:1052. doi: 10.3389/fimmu.2018.01052. eCollection 2018.
Natural killer group 2D (NKG2D) is a well-characterized activating receptor expressed on many immune cells, including invariant natural killer T (iNKT) cells. These cells were shown to be responsible of liver injury in the model of concanavalin A (Con A)-induced hepatitis, considered to be an experimental model of human autoimmune hepatitis. In this study, we investigated whether NKG2D plays a role in the hepatitis induced by iNKT cell-mediated immune response to Con A. By using killer cell lectin-like receptor subfamily K, member 1 deficient () mice, we found that the absence of NKG2D reduced the hepatic injury upon Con A administration. This was not due to an intrinsic functional defect of NKG2D-deficient iNKT cells as mice missing NKG2D have normal distribution and function of iNKT cells. Furthermore, increased resistance to Con A-induced hepatitis was confirmed using neutralizing anti-NKG2D antibodies. The reduced pathogenic effect of Con A in the absence of NKG2D correlates with a reduction in pathogenic cytokine production and FAS-Ligand (FAS-L) expression by iNKT cells. We also found that Con A administration led to an increase in the retinoic acid early inducible (RAE-1) surface expression on wild-type hepatocytes. Finally, we found that Con A has no direct action on FAS-L expression or cytokine production by iNKT cells and thus propose that NKG2D-L expression on stressed hepatocytes promote cytotoxic activity of iNKT cells its interaction with NKG2D contributing to hepatic injury. In conclusion, our results highlight NKG2D as an essential receptor required for the activation of iNKT cells in Con A-induced hepatitis and indicate that it represents a potential drug target for prevention of autoimmune hepatitis.
自然杀伤细胞群 2D(NKG2D)是一种在许多免疫细胞上表达的特征明确的激活受体,包括不变自然杀伤 T(iNKT)细胞。这些细胞被证明在伴刀豆球蛋白 A(Con A)诱导的肝炎模型中导致肝损伤,被认为是人类自身免疫性肝炎的实验模型。在这项研究中,我们研究了 NKG2D 是否在 iNKT 细胞介导的对 Con A 的免疫反应引起的肝炎中发挥作用。通过使用杀伤细胞凝集素样受体亚家族 K,成员 1 缺陷()小鼠,我们发现 NKG2D 的缺失减少了 Con A 给药后的肝损伤。这不是由于 NKG2D 缺陷的 iNKT 细胞的固有功能缺陷引起的,因为缺乏 NKG2D 的小鼠具有正常分布和功能的 iNKT 细胞。此外,使用中和抗 NKG2D 抗体证实了对 Con A 诱导的肝炎的抵抗力增加。在缺乏 NKG2D 的情况下,Con A 的致病作用降低与 iNKT 细胞产生的致病细胞因子和 Fas 配体(FAS-L)表达减少相关。我们还发现,Con A 给药导致野生型肝细胞表面表达的视黄酸早期诱导(RAE-1)增加。最后,我们发现 Con A 对 iNKT 细胞的 Fas-L 表达或细胞因子产生没有直接作用,因此我们提出应激肝细胞上的 NKG2D-L 表达促进 iNKT 细胞的细胞毒性活性及其与 NKG2D 的相互作用导致肝损伤。总之,我们的结果强调了 NKG2D 作为 Con A 诱导的肝炎中 iNKT 细胞激活所必需的受体,并表明它是预防自身免疫性肝炎的潜在药物靶标。